- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00806689
Full Disclosure Observational Cardiac Rhythm Documentation Follow-up After Surgical Atrial Fibrillation Therapy
24 hour Holter monitoring (24HM) is commonly used to assess cardiac rhythm after surgical therapy of atrial fibrillation. This "snapshot" rhythm documentation leaves a large diagnostic window of non recorded atrial arrhythmias and as such a large amount of uncertainty in follow-up result assessment. To improve accuracy of rhythm surveillance thus gaining a more "real-life" scenario of post surgical ablation therapy cardiac rhythm a new insertable cardiac rhythm monitor device (Reveal® XT 9525, Medtronic Inc., Minneapolis, MN, USA) with full observational continuous heart rhythm documentation is implanted.
In order to verify different follow-up strategies after surgical atrial fibrillation therapy, a comparison of different follow-up scenarios (symptoms, different cardiac documentation devices i.e. ECG and 24 hour Holter monitor, at different follow-up time points) is performed intraindividually. Thus the reliability of these devices and follow-up strategies to define success after ablation therapy is evaluated.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Anticipé)
Contacts et emplacements
Lieux d'étude
-
-
Schleswig-Holstein
-
Luebeck, Schleswig-Holstein, Allemagne, 23538
- Recrutement
- Clinic for Cardiac and Thoracic Vascular Surgery, University of Lübeck, Germany
-
Contact:
- Hans-H. Sievers, M.D.
- Numéro de téléphone: 2108 0049451500
- E-mail: h.sievers@herzchirurgie-luebeck.de
-
Contact:
- Thorsten Hanke, M.D.
- Numéro de téléphone: 2108 0049451500
- E-mail: Thorsten.Hanke@uk-sh.de
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- patients in atrial fibrillation (AF duration >4 months)being scheduled for cardiac surgery
- patients with lone atrial fibrillation being scheduled for surgical AF treatment
Exclusion Criteria:
- failure to provide informed consent
- current participation in another clinical trial
- organic cause of atrial fibrillation (hyperthyroidism etc.)
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
---|---|
Cardiac surgery patients
Patients in atrial fibrillation being scheduled for cardiac surgery and concomitant ablation procedure
|
post surgical procedure implantation of insertable event recorder for long time heart rhythm surveillance afte ablation therapy
Autres noms:
During cardiac surgery after stand alone or concomitant ablation procedure, an insertable loop recorder will be implanted subcutaneously in left pectoral region.
After surgery, patients will be monitored regularly in a quarterly basis by performing telemetry of the device in the outpatient clinic.
Furthermore, home telemetry will be performed once a month for optimal heart rhythm observation.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
Atrial fibrillation burden development after surgical ablation therapy
Délai: 3 years
|
3 years
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
---|---|
Comparison of different cardiac rhythm documentation strategies to define success after ablation therapy
Délai: 3 years
|
3 years
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Directeur d'études: Hans-H. Sievers, M.D., Clinic for Cardiac and Thoracic Vascular Surgery, University of Luebeck, Germany
- Chercheur principal: Thorsten Hanke, M.D., Clinic for Cardiac and Thoracic Vascular Surgery, University of Luebeck, Germany
- Chaise d'étude: Ulrich Stierle, M.D., Clinic for Cardiac and Thoracic Vascular Surgery, University of Luebeck, Germany
Publications et liens utiles
Publications générales
- Hanke T, Charitos EI, Stierle U, Karluss A, Kraatz E, Graf B, Hagemann A, Misfeld M, Sievers HH. Twenty-four-hour holter monitor follow-up does not provide accurate heart rhythm status after surgical atrial fibrillation ablation therapy: up to 12 months experience with a novel permanently implantable heart rhythm monitor device. Circulation. 2009 Sep 15;120(11 Suppl):S177-84. doi: 10.1161/CIRCULATIONAHA.108.838474.
- Charitos EI, Ziegler PD, Stierle U, Robinson DR, Graf B, Sievers HH, Hanke T. Atrial fibrillation burden estimates derived from intermittent rhythm monitoring are unreliable estimates of the true atrial fibrillation burden. Pacing Clin Electrophysiol. 2014 Sep;37(9):1210-8. doi: 10.1111/pace.12389. Epub 2014 Mar 25.
- Charitos EI, Ziegler PD, Stierle U, Robinson DR, Graf B, Sievers HH, Hanke T. How often should we monitor for reliable detection of atrial fibrillation recurrence? Efficiency considerations and implications for study design. PLoS One. 2014 Feb 12;9(2):e89022. doi: 10.1371/journal.pone.0089022. eCollection 2014.
- Charitos EI, Stierle U, Ziegler PD, Baldewig M, Robinson DR, Sievers HH, Hanke T. A comprehensive evaluation of rhythm monitoring strategies for the detection of atrial fibrillation recurrence: insights from 647 continuously monitored patients and implications for monitoring after therapeutic interventions. Circulation. 2012 Aug 14;126(7):806-14. doi: 10.1161/CIRCULATIONAHA.112.098079. Epub 2012 Jul 23. Erratum In: Circulation. 2012 Sep 25;126(13):e216.
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 08-046
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .